Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q9FU
|
||||
Former ID |
DNC011045
|
||||
Drug Name |
(S)-1-(5,6-difluoro-1H-indol-1-yl)propan-2-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551219] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H12F2N2
|
||||
Canonical SMILES |
CC(CN1C=CC2=CC(=C(C=C21)F)F)N
|
||||
InChI |
1S/C11H12F2N2/c1-7(14)6-15-3-2-8-4-9(12)10(13)5-11(8)15/h2-5,7H,6,14H2,1H3/t7-/m0/s1
|
||||
InChIKey |
MYZDBEVPJGKIQS-ZETCQYMHSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [551219] | |
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [551219] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.